Clinical characteristics that portend a positive Xpert Ultra test result in patients with pleural tuberculosis.

pleural TB

Journal

African journal of thoracic and critical care medicine
ISSN: 2617-0205
Titre abrégé: Afr J Thorac Crit Care Med
Pays: South Africa
ID NLM: 101751995

Informations de publication

Date de publication:
2019
Historique:
accepted: 20 05 2019
entrez: 21 7 2021
pubmed: 31 7 2019
medline: 31 7 2019
Statut: epublish

Résumé

The performance of Xpert-MTB/RIF, including the newer Xpert Ultra test, for the diagnosis of pleural TB is poor (~28 - 38%). There are no data on patient characteristics that portend a positive Xpert-Ultra test in pleural fluid. These characteristics could be useful for selecting patients for Xpert-Ultra testing, thus maximising benefits of a positive test, while minimising cost. To determine the clinical, radiological, microbiological and biochemical characteristics associated with Xpert-Ultra positivity in patients with suspected pleural tuberculosis. We performed a subgroup analysis of a prospective observational cohort (N=165 patients with suspected pleural TB) evaluating same-day diagnostic tools for pleural tuberculosis. Forty-nine patients with confirmed pleural tuberculosis (culture and/or histology) were included in the final analysis. Of the 49 participants, 17 (35%) were female and 9 (18.4%) were HIV-infected. In the multivariate analysis including demographic, radiological and pleural fluid test characteristics, there were no independent predictors of Xpert-Ultra positivity. However, when pleural fluid test results were excluded, and when only rapidly ascertainable pre-test factors (demographic and radiologic variables) were considered, the multivariable analysis showed that only a chest X-ray (CXR) suggestive of active TB (cavities, consolidation and hilar lymphadenopathy) was associated with Xpert-Ultra positivity (p=0.021). Notably, only 22% (n=11/49) of the participants had a CXR suggestive of active TB and of these, 73% (n=8/11) had a positive Xpert-Ultra result. CXR features suggestive of active TB are significantly associated with a positive Xpert-Ultra test result on pleural fluid. These data inform clinical practice in resource-poor settings.

Sections du résumé

BACKGROUND BACKGROUND
The performance of Xpert-MTB/RIF, including the newer Xpert Ultra test, for the diagnosis of pleural TB is poor (~28 - 38%). There are no data on patient characteristics that portend a positive Xpert-Ultra test in pleural fluid. These characteristics could be useful for selecting patients for Xpert-Ultra testing, thus maximising benefits of a positive test, while minimising cost.
OBJECTIVES OBJECTIVE
To determine the clinical, radiological, microbiological and biochemical characteristics associated with Xpert-Ultra positivity in patients with suspected pleural tuberculosis.
METHODS METHODS
We performed a subgroup analysis of a prospective observational cohort (N=165 patients with suspected pleural TB) evaluating same-day diagnostic tools for pleural tuberculosis. Forty-nine patients with confirmed pleural tuberculosis (culture and/or histology) were included in the final analysis.
RESULTS RESULTS
Of the 49 participants, 17 (35%) were female and 9 (18.4%) were HIV-infected. In the multivariate analysis including demographic, radiological and pleural fluid test characteristics, there were no independent predictors of Xpert-Ultra positivity. However, when pleural fluid test results were excluded, and when only rapidly ascertainable pre-test factors (demographic and radiologic variables) were considered, the multivariable analysis showed that only a chest X-ray (CXR) suggestive of active TB (cavities, consolidation and hilar lymphadenopathy) was associated with Xpert-Ultra positivity (p=0.021). Notably, only 22% (n=11/49) of the participants had a CXR suggestive of active TB and of these, 73% (n=8/11) had a positive Xpert-Ultra result.
CONCLUSION CONCLUSIONS
CXR features suggestive of active TB are significantly associated with a positive Xpert-Ultra test result on pleural fluid. These data inform clinical practice in resource-poor settings.

Identifiants

pubmed: 34286247
doi: 10.7196/AJTCCM.2019.v25i2.011
pmc: PMC8278986
doi:

Types de publication

Journal Article

Langues

eng

Déclaration de conflit d'intérêts

Conflicts of interest: None.

Références

Braz J Infect Dis. 2007 Feb;11(1):83-8
pubmed: 17625733
Int J Infect Dis. 2018 Apr;69:103-107
pubmed: 29408477
J Thorac Dis. 2015 Jun;7(6):981-91
pubmed: 26150911
Expert Rev Anti Infect Ther. 2014 May;12(5):633-47
pubmed: 24717112
BMC Pulm Med. 2014 Apr 08;14:58
pubmed: 24708530
J Clin Microbiol. 2016 Apr;54(4):1133-6
pubmed: 26818675
Radiology. 2011 Mar;258(3):776-84
pubmed: 21193598
J Clin Microbiol. 2011 Dec;49(12):4341-2
pubmed: 21998430
Lancet. 2016 Mar 19;387(10024):1211-26
pubmed: 26377143
mBio. 2017 Aug 29;8(4):
pubmed: 28851844

Auteurs

E Makambwa (E)

Centre for Lung Infection and Immunity, Division of Pulmonology, Department of Medicine and UCT Lung Institute, University of Cape Town, South Africa.

H R Maboreke (HR)

Centre for Lung Infection and Immunity, Division of Pulmonology, Department of Medicine and UCT Lung Institute, University of Cape Town, South Africa.

M Fadul (M)

Centre for Lung Infection and Immunity, Division of Pulmonology, Department of Medicine and UCT Lung Institute, University of Cape Town, South Africa.

R Meldau (R)

Centre for Lung Infection and Immunity, Division of Pulmonology, Department of Medicine and UCT Lung Institute, University of Cape Town, South Africa.

M Dhansay (M)

Centre for Lung Infection and Immunity, Division of Pulmonology, Department of Medicine and UCT Lung Institute, University of Cape Town, South Africa.

A Esmail (A)

Centre for Lung Infection and Immunity, Division of Pulmonology, Department of Medicine and UCT Lung Institute, University of Cape Town, South Africa.

K Dheda (K)

Centre for Lung Infection and Immunity, Division of Pulmonology, Department of Medicine and UCT Lung Institute, University of Cape Town, South Africa.
London School of Hygiene and Tropical Medicine, London, United Kingdom.

Classifications MeSH